Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
about
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in UgandaTrends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.Enrolment trends in a comprehensive HIV programme in rural north-central Nigeria: improved care indices, but declining quality of clinical data over time.Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.Cryptococcal meningitis: A neglected NTD?Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiationAdvanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011.Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysisCharacteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community.Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.Implementation of Point-of-Care Diagnostics Leads to Variable Uptake of Syphilis, Anemia and CD4+ T-Cell Count Testing in Rural Maternal and Child Health Clinics.Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μLFactors Associated with HIV Prevalence and HIV Testing in Sierra Leone: Findings from the 2008 Demographic Health SurveyMass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South AfricaAdvanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in CambodiaRethinking HIV prevention to prepare for oral PrEP implementation for young African womenAdvanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.New indicators for delay in initiation of antiretroviral treatment: estimates for CameroonThe clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B+ in Southern Malawi.Attrition From Human Immunodeficiency Virus Treatment Programs in Africa: A Longitudinal Ecological Analysis Using Data From 307 144 Patients Initiating Antiretroviral Therapy Between 2005 and 2010.Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.Delayed entry to care by men with HIV infection in Kumasi, GhanaSystematic review of strategies to increase men's HIV-testing in sub-Saharan AfricaFactors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study.Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa.Human immunodeficiency virus care cascade among sub-populations in Rakai, Uganda: an observational study.Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda.Outcomes among HIV-infected children initiating HIV care and antiretroviral treatment in Ethiopia.Self-disclosure of HIV status, disclosure counseling, and retention in HIV care in Cameroon.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.Determinants of virological failure and antiretroviral drug resistance in Mozambique.Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho."I did not see a need to get tested before, everything was going well with my health": a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa.Human immunodeficiency virus care cascade among sub-populations in Rakai, Uganda: an observational study.Gender Differences and Psychosocial Factors Associated with Quality of Life Among ART Initiators in Oromia, Ethiopia.
P2860
Q28551745-70E94461-27AF-4B8F-A894-44653F11D3D9Q30388278-266D8CB0-DD71-43E1-A38C-4694D8B2091EQ30919398-27C8D8A1-AFC1-4679-936B-AB971056D8FBQ33576831-5809059B-B483-4E7E-A94E-599326BFB57BQ33852819-73F630E6-1E61-4D30-92F3-F3D23D40E47CQ34633232-3E22E118-5CB4-4606-AC7F-FEE1F05B3583Q35180760-62F8296C-2C54-4DB8-B68F-8D49D8BCD3B6Q35197266-1DBBFC87-6E3C-4369-B1D5-93E9B2F45229Q35620659-523DDF1F-638D-4FCC-BED0-728430A02CBAQ35668867-24DC7B87-4D45-4ED9-AD0A-867E9E7378CCQ35673424-6FA75104-57AE-4F02-A95D-0C2A7330094DQ35755780-593F9EE5-4638-4088-8451-CA2BC8444BB0Q35777009-24AC5BE1-110B-43D6-8387-9661ACC88B18Q35801691-0ECC7803-8909-488F-9688-C0A69CD30DBDQ35850330-12F01ECF-0A65-4E26-9D6E-20665A9E16E2Q35852326-355C1EE9-B589-4968-9BCC-03D6E491A054Q35875710-E42FE509-2FFD-4C6E-BE0C-FD72D0B723E9Q35993151-984AEC82-2085-48C7-AB63-A7EEE0A6EADFQ36089497-94AB0DF9-63D1-4D63-A6A2-C4CCEB60C423Q36215535-B8F067F1-E0D0-48D2-B051-6A17ED39AF63Q36230357-79D78C1C-6FD9-4567-A531-446CC4C7A7CDQ36318628-6D1BE255-501F-4867-A862-05D2D877869FQ36349654-2BFBE96A-739F-4AE9-BB85-35B42319D7F2Q36519687-8B23C68F-6861-45A6-AEDB-6D815C790F17Q36762725-A93E0660-0E36-426E-AB83-931F0D271145Q36837250-9EE7E803-CCCD-4C05-8625-4523D5B2DBC2Q37414765-AF32FCAF-5CE1-49A5-B601-E6887B6C04EEQ37520078-88FD706F-8AB9-4446-942F-F1AE6413B9BAQ37608851-283FB765-E7BC-4401-9243-963EC8425A6DQ38849497-8E72DF04-8E1F-48E0-8DCA-04985390BE29Q38851911-8CCDAD43-8DE9-4230-B855-8FD144E31E5DQ38852957-1BB4F7DE-4FF1-4901-819B-1E07284C76E4Q39032531-4EB04327-7D13-44F6-B9FC-BFA25BD185FAQ39063999-37CBDBEF-324B-4A00-B332-C78616DD125AQ39379643-70535B69-DDB3-45BA-BD9B-22DD45F1894FQ39414398-47C2BFD1-08BC-4358-8B8F-FF4CA55DA514Q40055779-BBCA74A1-FA2B-48BC-BE2D-1AE965A26E6EQ40127809-D32E4D04-C304-41F7-94FA-5C75AA6ABEAFQ40163483-C6E3FC9E-F403-49E7-A0D2-301DD5635BA6Q40709335-E1F50804-401C-4F7F-BE57-017BD64F7441
P2860
Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Advanced HIV disease at entry ...... sub-saharan African countries.
@en
Advanced HIV disease at entry ...... sub-saharan African countries.
@nl
type
label
Advanced HIV disease at entry ...... sub-saharan African countries.
@en
Advanced HIV disease at entry ...... sub-saharan African countries.
@nl
prefLabel
Advanced HIV disease at entry ...... sub-saharan African countries.
@en
Advanced HIV disease at entry ...... sub-saharan African countries.
@nl
P2093
P2860
P50
P356
P1476
Advanced HIV disease at entry ...... sub-saharan African countries.
@en
P2093
Identifying Optimal Models of HIV Care in sub-Saharan Africa Collaboration
Maria Lahuerta
Multi-level determinants of late ART initiation in sub-Saharan Africa Team and
Robert H Remien
Sarah Gorrell Kulkarni
Susie Hoffman
Yingfeng Wu
P2860
P304
P356
10.1093/CID/CIT724
P407
P577
2013-11-05T00:00:00Z